Article Details
Retrieved on: 2024-02-06 17:49:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SOUTH SAN FRANCISCO, Calif., February 06, 2024--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here